The intricate interplay between AKT signaling and mitochondrial dynamics in renal injury showcases the potential therapeutic relevance of targeting mitochondrial AKT to mitigate AKI and impede the subsequent development of CKD. This evidence concerns the gene AKT1 and chronic kidney disease.